Developer docs
API playgroundTry for free, no card

Search company profiles

PolyPeptide Group

Full company profile

uuid003my7c

Namestring
PolyPeptide Group
Legal namestring
Polypeptide group
Company typeenum
Private
Founded yearint
2014
Descriptiontext

PolyPeptide Group operates a direct-to-consumer e-commerce storefront (polypeptide.group) selling research-grade peptides globally. Founded in 2014, the company markets a catalog of approximately fifteen peptide products, with Somatropin (recombinant human growth hormone, 191 amino acids) as its core offering, supplemented by a range of research peptides spanning growth hormone secretagogues (CJC-1295, Ipamorelin, GHRP-2, GHRP-6), IGF-1 variants (IGF1-LR3, PEG-MGF), recovery and pigmentation peptides (TB-500, Melanotan 2, Frag 176-191, Follistatin), and gonadotropins (HCG, Gonadorelin). All SKUs are labeled "for research use only," yet the website's marketing language is overtly consumer-oriented, emphasizing anti-aging, cellular regeneration, fat metabolism, and hormone-replacement use cases for individual buyers. Shipments include authenticity features (original cartons, holograms, serial codes) intended to deter counterfeit competition.

The underlying technology is described as peptide bioregulation — identification and isolation of biologically active short peptides — supported by an asserted "colossal scientific and laboratory base," though no specific scientific personnel, patents, certifications, or manufacturing facilities are disclosed. The business model is a straightforward one-time-purchase DTC storefront with no disclosed pricing, no subscription tiers, and no enterprise or B2B contracts documented; the only public contact channel is a single email address and contact form with weekday business hours. A May 2023 strategic partnership with Numaferm GmbH focused on sustainable peptide manufacturing is the most significant third-party relationship on record, but no downstream operational impact (capacity, supply, co-developed products) is documented in the source data.

Key structural caveats: the firmographics short description characterizes the company as a CDMO for pharma and biotech — this is inconsistent with the actual website, which is a small consumer storefront, and is treated as unreliable for purposes of this analysis. No revenue, funding, headcount specifics, management team, regulatory clearances, or financial statements are disclosed. The product category (research-use peptides marketed with consumer health claims) operates in a gray regulatory zone that materially affects the risk profile.

Short descriptiontext

PolyPeptide Group is a 2014-founded direct-to-consumer e-commerce seller of research-grade peptides, with Somatropin as its core product and ~15 ancillary peptide SKUs, marketing anti-aging and cellular-regeneration benefits to individual global buyers via its own website.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
Markets served

Serves global market

Keyword5 values
peptide manufacturing, recombinant growth hormone, research peptides, pharmaceutical peptides, peptide bioregulation
Industry4 codes
PRIMARYHLAAAAAH
Therapeutic Peptides & Protein/Peptide Biologics
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)
SECONDARYHLAAAAAB
Recombinant Protein Therapeutics (enzymes, hormones, growth factors)
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)
SECONDARYAFAJAKAG
Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYCRADAOAJ
Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids)
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Biological Products, (No Disgnostic Substances)2836
Product category
Pharmaceutical peptides
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Peptide Product Sales
TypeOne Time License
Description

Direct sales of peptide products including Somatropin, TB-500, PEG-MGF, Melanotan 2, Ipamorelin, IGF1-LR3, HCG, Gonadorelin, GHRP-6, GHRP-2, Frag(176-191), Follistatin, and CJC-1295. Products are shipped directly to customers with authenticity verification.

polypeptide.group
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

PolyPeptide Group develops and sells peptide products directly to end customers through its e-commerce website. The portfolio centers on recombinant human growth hormone (Somatropin 191aa) and a catalog of research peptides covering growth hormone secretagogues, IGF variants, melanocortin peptides, tissue-recovery peptides, and gonadotropins. Products ship in original cartons with protective holograms and serial codes for authenticity verification.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Peptides are cleaved to amino acids and used as building material by the body after performing their function
+1 more record
Product overview1 text field

PolyPeptide Group is a pharmaceutical peptide products company established in 2014, specializing in recombinant human growth hormone (Somatropin 191aa) and research peptides for biological research. The company's product portfolio centers on Somatropin as the core pharmaceutical product for treating growth hormone deficiency, supported by a range of research peptides including growth hormone-releasing peptides (GHRP-2, GHRP-6, CJC-1295, Ipamorelin), IGF-related peptides (IGF1-LR3, PEG-MGF, Follistatin), pigmenting peptides (Melanotan 2), and tissue-recovery peptides (TB-500, Frag 176-191), along with gonadotropins (HCG, Gonadorelin). All peptide products are labeled for laboratory research purposes only.

Product and service13 records
1Somatropin 191aa
CategoryRecombinant growth hormone pharmaceutical
Description

Recombinant human growth hormone (rDNA origin injection) of 191 amino acids identical to natural pituitary growth hormone, used to treat growth failure in children and growth hormone deficiency in adults, including cases of Noonan Syndrome, Turner Syndrome, and short stature born small for gestational age.

2CJC-1295
CategoryGrowth hormone secretagogue peptide
Description

30-amino-acid peptide hormone analogue of somatoliberin that stimulates growth hormone secretion and can bioconjugate with serum albumin to extend half-life and therapeutic effect.

3GHRP-6
CategoryGrowth hormone secretagogue peptide
Description

Hexapeptide growth hormone secretagogue that stimulates ghrelin receptors and promotes endogenous growth hormone production.

4GHRP-2
CategoryGrowth hormone secretagogue peptide
Description

Growth hormone-releasing peptide that stimulates independent growth hormone production through pituitary and hypothalamic receptor interaction.

5Ipamorelin
CategoryGrowth hormone secretagogue peptide
Description

Growth hormone stimulating peptide from the GHRP group that mimics ghrelin effects and enhances growth hormone secretion with minimized side effects.

6IGF1-LR3
CategoryIGF-related peptide
Description

Insulin-like growth factor-1 variant with extended half-life that provides anabolic effects including increased muscle mass through hyperplasia.

7PEG-MGF
CategoryIGF-related peptide
Description

Pegylated mechanical growth factor, an isoform of insulin-like growth factor formed after physical exercise that promotes muscle cell division and growth.

8Follistatin 344
CategoryIGF-related peptide
Description

Protein with high affinity for binding to activin and myostatin, functioning as an inhibitor of these proteins to promote muscle growth.

9Melanotan 2
CategoryMelanocortin peptide
Description

Analogue of melanocyte stimulating hormone (alpha-MSH) that activates melanin production for skin tanning and provides UV protection.

10TB-500
CategoryTissue-repair peptide
Description

Synthetic analogue of natural thymosin beta-4, a peptide hormone involved in healing, recovery from trauma, and immunity strengthening.

11HGH Frag (176-191)
CategoryMetabolic / fat-loss peptide
Description

16-amino-acid fragment of growth hormone that stimulates lipolysis and suppresses subcutaneous fat formation without affecting blood sugar levels.

12HCG 2000 IU
CategoryGonadotropin peptide
Description

Human chorionic gonadotropin (2000 IU lyophilizate) that mimics luteinizing hormone action for use in fertility treatments and testosterone stimulation.

13Gonadorelin
CategoryGonadotropin peptide
Description

Gonadotropin-releasing hormone (GnRH) polypeptide that stimulates pituitary gonadotropin release and supports testosterone production and spermatogenesis.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-05-01
Description

Partnership established in May 2023 between PolyPeptide Group AG and Numaferm GmbH focused on sustainable peptide manufacturing innovations. This collaboration highlights strategic industry partnerships driving sustainable development in the peptide manufacturing sector.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
1Limitless Life Nootropics
TypeDirect peer
Description

Online retailer of novel compounds including research peptides, nootropics, and longevity supplements; competes for the same DTC wellness/bioregulation buyer seeking growth-hormone-axis products.

TypeBroad incumbent
Description

Global leader in therapeutic growth hormone (Norditropin, Sogroya) with established regulatory, manufacturing, and physician-channel infrastructure. Represents the legitimate, branded incumbent whose prescription HGH business PolyPeptide's Somatropin indirectly competes against.

TypeDirect peer
Description

Online research-peptide retailer offering Somatropin, GHRP-6, Melanotan II, and other recombinant and synthetic peptides targeted at the same research/longevity buyer as PolyPeptide Group. Closest comparable in catalog, pricing, and DTC delivery model.

4Amino Asylum (Peptide Source)
TypeDirect peer
Description

Specialty online retailer of research-use-only peptides including growth hormone secretagogues, melanocortins, and recovery peptides — directly comparable catalog and customer base to PolyPeptide Group's research-peptide line.

5PolyPeptide Group AG (the legitimate Swiss-listed CDMO)
TypeEmerging player
Description

Publicly-listed, EU-based peptide and oligonucleotide CDMO manufacturing APIs for pharma and biotech. Relevant emerging/thematic peer because the supplied PolyPeptide Group short description references the same CDMO business model — brand-name overlap demands diligence to ensure the two are distinct.

TypeBroad incumbent
Description

Leading peptide and oligonucleotide CDMO serving pharmaceutical customers worldwide with GMP-grade manufacturing. Comparable because PolyPeptide's 'colossal scientific and laboratory base' claims map to Bachem's manufacturing platform expertise at industrial scale.

7Bioactive Peptides (research peptide vendors — category)
TypeDirect peer
Description

Independent research-peptide vendors selling GHRPs, CJC-1295, IGF-1 variants, and HCG online with similar 'research only' positioning. Represents the direct peer set PolyPeptide Group competes with for share of wallet.

TypeBroad incumbent
Description

Sells the Genotropin brand of recombinant somatropin through physician and specialty pharmacy channels. Comparable as a manufacturer and distributor of the recombinant human growth hormone at the center of PolyPeptide Group's core product.

TypeBroad incumbent
Description

Major diversified pharmaceutical company with a long-established Humatrope recombinant growth hormone franchise serving the same adult and pediatric growth-hormone-deficiency indications that PolyPeptide's Somatropin targets.

TypeOthers
Description

Telemedicine and clinic channels dispensing growth hormone, peptides, and hormone-optimization therapies to consumers. Comparable as a downstream customer/distribution channel that PolyPeptide's research-positioned products could increasingly feed.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PolyPeptide Group

Pharmaceutical peptidespolypeptide.group

PolyPeptide Group is a 2014-founded direct-to-consumer e-commerce seller of research-grade peptides, with Somatropin as its core product and ~15 ancillary peptide SKUs, marketing anti-aging and cellular-regeneration benefits to individual global buyers via its own website.

What PolyPeptide Group does

PolyPeptide Group operates a direct-to-consumer e-commerce storefront (polypeptide.group) selling research-grade peptides globally. Founded in 2014, the company markets a catalog of approximately fifteen peptide products, with Somatropin (recombinant human growth hormone, 191 amino acids) as its core offering, supplemented by a range of research peptides spanning growth hormone secretagogues (CJC-1295, Ipamorelin, GHRP-2, GHRP-6), IGF-1 variants (IGF1-LR3, PEG-MGF), recovery and pigmentation peptides (TB-500, Melanotan 2, Frag 176-191, Follistatin), and gonadotropins (HCG, Gonadorelin). All SKUs are labeled "for research use only," yet the website's marketing language is overtly consumer-oriented, emphasizing anti-aging, cellular regeneration, fat metabolism, and hormone-replacement use cases for individual buyers. Shipments include authenticity features (original cartons, holograms, serial codes) intended to deter counterfeit competition.

The underlying technology is described as peptide bioregulation — identification and isolation of biologically active short peptides — supported by an asserted "colossal scientific and laboratory base," though no specific scientific personnel, patents, certifications, or manufacturing facilities are disclosed. The business model is a straightforward one-time-purchase DTC storefront with no disclosed pricing, no subscription tiers, and no enterprise or B2B contracts documented; the only public contact channel is a single email address and contact form with weekday business hours. A May 2023 strategic partnership with Numaferm GmbH focused on sustainable peptide manufacturing is the most significant third-party relationship on record, but no downstream operational impact (capacity, supply, co-developed products) is documented in the source data.

Key structural caveats: the firmographics short description characterizes the company as a CDMO for pharma and biotech — this is inconsistent with the actual website, which is a small consumer storefront, and is treated as unreliable for purposes of this analysis. No revenue, funding, headcount specifics, management team, regulatory clearances, or financial statements are disclosed. The product category (research-use peptides marketed with consumer health claims) operates in a gray regulatory zone that materially affects the risk profile.

PolyPeptide Group firmographics

Firmographics
Name
PolyPeptide Group
Legal name
Polypeptide group
Website
https://polypeptide.group
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
251–500 employees
Short description
PolyPeptide Group is a 2014-founded direct-to-consumer e-commerce seller of research-grade peptides, with Somatropin as its core product and ~15 ancillary peptide SKUs, marketing anti-aging and cellular-regeneration benefits to individual global buyers via its own website.
Ownership category
akta.pro rank

PolyPeptide Group industry classification

Industry
Product category
Pharmaceutical peptides
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAAAAAH
Therapeutic Peptides & Protein/Peptide Biologics
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)
SECONDARYHLAAAAAB
Recombinant Protein Therapeutics (enzymes, hormones, growth factors)
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)
SECONDARYAFAJAKAG
Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
SECONDARYCRADAOAJ
Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids)

Keywords

  • Peptide manufacturing
  • Recombinant growth hormone
  • Research peptides
  • Pharmaceutical peptides
  • Peptide bioregulation

PolyPeptide Group business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales

Revenue model

  1. Peptide Product Sales: Direct sales of peptide products including Somatropin, TB-500, PEG-MGF, Melanotan 2, Ipamorelin, IGF1-LR3, HCG, Gonadorelin, GHRP-6, GHRP-2, Frag(176-191), Follistatin, and CJC-1295. Products are shipped directly to customers with authenticity verification.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

PolyPeptide Group product offering

Product offering

Core offering

PolyPeptide Group develops and sells peptide products directly to end customers through its e-commerce website. The portfolio centers on recombinant human growth hormone (Somatropin 191aa) and a catalog of research peptides covering growth hormone secretagogues, IGF variants, melanocortin peptides, tissue-recovery peptides, and gonadotropins. Products ship in original cartons with protective holograms and serial codes for authenticity verification.

Product overview

PolyPeptide Group is a pharmaceutical peptide products company established in 2014, specializing in recombinant human growth hormone (Somatropin 191aa) and research peptides for biological research. The company's product portfolio centers on Somatropin as the core pharmaceutical product for treating growth hormone deficiency, supported by a range of research peptides including growth hormone-releasing peptides (GHRP-2, GHRP-6, CJC-1295, Ipamorelin), IGF-related peptides (IGF1-LR3, PEG-MGF, Follistatin), pigmenting peptides (Melanotan 2), and tissue-recovery peptides (TB-500, Frag 176-191), along with gonadotropins (HCG, Gonadorelin). All peptide products are labeled for laboratory research purposes only.

Differentiator

Problem solved

Functional benefit

Products and services

  • Somatropin 191aa Recombinant human growth hormone (rDNA origin injection) of 191 amino acids identical to natural pituitary growth hormone, used to treat growth failure in children and growth hormone deficiency in adults, including cases of Noonan Syndrome, Turner Syndrome, and short stature born small for gestational age.
  • CJC-1295 30-amino-acid peptide hormone analogue of somatoliberin that stimulates growth hormone secretion and can bioconjugate with serum albumin to extend half-life and therapeutic effect.
  • GHRP-6 Hexapeptide growth hormone secretagogue that stimulates ghrelin receptors and promotes endogenous growth hormone production.
  • GHRP-2 Growth hormone-releasing peptide that stimulates independent growth hormone production through pituitary and hypothalamic receptor interaction.
  • Ipamorelin Growth hormone stimulating peptide from the GHRP group that mimics ghrelin effects and enhances growth hormone secretion with minimized side effects.
  • IGF1-LR3 Insulin-like growth factor-1 variant with extended half-life that provides anabolic effects including increased muscle mass through hyperplasia.
  • PEG-MGF Pegylated mechanical growth factor, an isoform of insulin-like growth factor formed after physical exercise that promotes muscle cell division and growth.
  • Follistatin 344 Protein with high affinity for binding to activin and myostatin, functioning as an inhibitor of these proteins to promote muscle growth.
  • Melanotan 2 Analogue of melanocyte stimulating hormone (alpha-MSH) that activates melanin production for skin tanning and provides UV protection.
  • TB-500 Synthetic analogue of natural thymosin beta-4, a peptide hormone involved in healing, recovery from trauma, and immunity strengthening.
  • HGH Frag (176-191) 16-amino-acid fragment of growth hormone that stimulates lipolysis and suppresses subcutaneous fat formation without affecting blood sugar levels.
  • HCG 2000 IU Human chorionic gonadotropin (2000 IU lyophilizate) that mimics luteinizing hormone action for use in fertility treatments and testosterone stimulation.
  • Gonadorelin Gonadotropin-releasing hormone (GnRH) polypeptide that stimulates pituitary gonadotropin release and supports testosterone production and spermatogenesis.

Quantifiable outcome

  • Peptides are cleaved to amino acids and used as building material by the body after performing their function
  • +1 more outcomes

Companies that use PolyPeptide Group

Customer profile

Segments2 records

Ideal customer profiles2 records

PolyPeptide Group technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

PolyPeptide Group partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Numaferm GmbHcoreStrategic or Co-development Partner · 1 May 2023Partnership established in May 2023 between PolyPeptide Group AG and Numaferm GmbH focused on sustainable peptide manufacturing innovations. This collaboration highlights strategic industry partnerships driving sustainable development in the peptide manufacturing sector.

Scale indicators2 records

Recent moves3 records

Expansion highlights3 records

PolyPeptide Group competitors and assessment

Company assessment

Direct peers

  • Limitless Life Nootropics: Online retailer of novel compounds including research peptides, nootropics, and longevity supplements; competes for the same DTC wellness/bioregulation buyer seeking growth-hormone-axis products.
  • Peptide Sciences: Online research-peptide retailer offering Somatropin, GHRP-6, Melanotan II, and other recombinant and synthetic peptides targeted at the same research/longevity buyer as PolyPeptide Group. Closest comparable in catalog, pricing, and DTC delivery model.
  • Amino Asylum (Peptide Source): Specialty online retailer of research-use-only peptides including growth hormone secretagogues, melanocortins, and recovery peptides — directly comparable catalog and customer base to PolyPeptide Group's research-peptide line.
  • Bioactive Peptides (research peptide vendors — category): Independent research-peptide vendors selling GHRPs, CJC-1295, IGF-1 variants, and HCG online with similar 'research only' positioning. Represents the direct peer set PolyPeptide Group competes with for share of wallet.

Broad incumbents

  • Novo Nordisk: Global leader in therapeutic growth hormone (Norditropin, Sogroya) with established regulatory, manufacturing, and physician-channel infrastructure. Represents the legitimate, branded incumbent whose prescription HGH business PolyPeptide's Somatropin indirectly competes against.
  • Bachem Holding AG: Leading peptide and oligonucleotide CDMO serving pharmaceutical customers worldwide with GMP-grade manufacturing. Comparable because PolyPeptide's 'colossal scientific and laboratory base' claims map to Bachem's manufacturing platform expertise at industrial scale.
  • Pfizer (Genotropin): Sells the Genotropin brand of recombinant somatropin through physician and specialty pharmacy channels. Comparable as a manufacturer and distributor of the recombinant human growth hormone at the center of PolyPeptide Group's core product.
  • Eli Lilly (Humatrope / eglume): Major diversified pharmaceutical company with a long-established Humatrope recombinant growth hormone franchise serving the same adult and pediatric growth-hormone-deficiency indications that PolyPeptide's Somatropin targets.

Emerging players

  • PolyPeptide Group AG (the legitimate Swiss-listed CDMO): Publicly-listed, EU-based peptide and oligonucleotide CDMO manufacturing APIs for pharma and biotech. Relevant emerging/thematic peer because the supplied PolyPeptide Group short description references the same CDMO business model — brand-name overlap demands diligence to ensure the two are distinct.

Others

  • Defy Medical / telemedicine HRT clinics: Telemedicine and clinic channels dispensing growth hormone, peptides, and hormone-optimization therapies to consumers. Comparable as a downstream customer/distribution channel that PolyPeptide's research-positioned products could increasingly feed.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

PolyPeptide Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PolyPeptide Group leadership team

Management profile

Number of profiles

PolyPeptide Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PolyPeptide Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PolyPeptide Group

What does PolyPeptide Group do?

PolyPeptide Group develops and sells peptide products directly to end customers through its e-commerce website. The portfolio centers on recombinant human growth hormone (Somatropin 191aa) and a catalog of research peptides covering growth hormone secretagogues, IGF variants, melanocortin peptides, tissue-recovery peptides, and gonadotropins. Products ship in original cartons with protective holograms and serial codes for authenticity verification.

Is PolyPeptide Group a public or private company?

PolyPeptide Group is a private company. It is classified as unknown and is currently operating.

When was PolyPeptide Group founded?

PolyPeptide Group was founded in 2014. It employs 251 to 500 people.

How does PolyPeptide Group make money?

One revenue line is on record: peptide Product Sales.

Who are PolyPeptide Group's main competitors?

Direct peers on record are Limitless Life Nootropics, Peptide Sciences, Amino Asylum (Peptide Source) and Bioactive Peptides (research peptide vendors — category). Broad incumbents are Novo Nordisk, Bachem Holding AG, Pfizer (Genotropin) and Eli Lilly (Humatrope / eglume). PolyPeptide Group AG (the legitimate Swiss-listed CDMO) is listed as an emerging player. Defy Medical / telemedicine HRT clinics is listed as an others.

Does PolyPeptide Group have an API?

No public API is recorded for PolyPeptide Group.

What industry is PolyPeptide Group in?

PolyPeptide Group's product category is Pharmaceutical peptides. Its primary akta.pro industry code is HLAAAAAH, Therapeutic Peptides & Protein/Peptide Biologics, with a secondary code of HLAAAAAB, Recombinant Protein Therapeutics (enzymes, hormones, growth factors). Its NAICS code is 325414 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales